Successful pregnancies in a patient with Takayasu arteritis and antiphospholipid syndrome, maintained on infliximab corticosteroid-free regimen: case-based review
Takayasu arteritis (TA) is a large vessel vasculitis affecting predominantly females below the age of 40. Patients with TA seem to be at increased risk for adverse pregnancy outcomes, resulting in mother or child complications. Although few studies analyzed the presence of antiphospholipid antibodie...
Gespeichert in:
Veröffentlicht in: | Rheumatology international 2024-07, Vol.44 (7), p.1359-1367 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1367 |
---|---|
container_issue | 7 |
container_start_page | 1359 |
container_title | Rheumatology international |
container_volume | 44 |
creator | Jovicic, Zikica Dragasevic, Sanja Petkovic, Ana Plesinac, Snezana Sokic Milutinovic, Aleksandra Stojanovic, Maja |
description | Takayasu arteritis (TA) is a large vessel vasculitis affecting predominantly females below the age of 40. Patients with TA seem to be at increased risk for adverse pregnancy outcomes, resulting in mother or child complications. Although few studies analyzed the presence of antiphospholipid antibodies (APLA) in TA patients, an association between antiphospholipid syndrome (APS) and TA is rarely reported in the literature, mainly in the form of case reports. In fact, very few data regarding pregnancy outcomes in patients with TA and APS are available. An active form of Crohn’s disease (CD) might be another risk factor strongly affecting the fertility rate. Here, we would like to present a 33-year-old woman with TA, double-positive APS and Crohn’s disease (CD). The report is followed by the literature review of the association of APLA and/or APS with TA, focusing on analyzing the pregnancy outcomes. To our knowledge, this is the first case describing two successful, naturally occurring pregnancies, in a patient suffering from TA, APS and CD, and maintained on infliximab, azathioprine, and a corticosteroid-free regimen. |
doi_str_mv | 10.1007/s00296-023-05440-0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2860401295</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2860401295</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-c990d952132925e2b3ce22364e2816ac38bafc4e27c23981257b6abd1e858a2f3</originalsourceid><addsrcrecordid>eNp9UUuP1iAUbYzGeegfcGFI3LgY9AItbd1NJr6SSVw4Ju4IpbczjC1ULnX8_o6_VPQbH3Hh4sAFzj0HOFX1SMAzAdA-JwDZaw5ScWjqGjjcqQ5FrVouNHy8-1d9UB0RXQOIVmu4Xx2oVjcKNBxW395vziHRtM1sTXgZbHAeifnALFtt9hgyu_H5il3YT3ZnaWM2ZUw-e2I2jAXZr1eRCma_-pHRLowpLnjCFutDLsCRxVAUp9l_9YsdmIspexep6EQ_8ikhsuLtFwwvmLOEfCjDWPa-eLx5UN2b7Ez48HY-rj68enlx9oafv3v99uz0nDsldeau72HsGymU7GWDclAOpVS6RtkJbZ3qBju5smqdVH0nZNMO2g6jwK7prJzUcfV0r7um-HlDymbx5HCebcC4kZGdhhqE7JtCffIP9TpuKZTbmfKtXXEVbV9Ycs9yKRIlnMyayvvTzggwPxI0-wRNSdD8TNBAaXp8K70NC46_W35FVghqT6ByFC4x_fH-j-x3Mn6p5Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3068236179</pqid></control><display><type>article</type><title>Successful pregnancies in a patient with Takayasu arteritis and antiphospholipid syndrome, maintained on infliximab corticosteroid-free regimen: case-based review</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Jovicic, Zikica ; Dragasevic, Sanja ; Petkovic, Ana ; Plesinac, Snezana ; Sokic Milutinovic, Aleksandra ; Stojanovic, Maja</creator><creatorcontrib>Jovicic, Zikica ; Dragasevic, Sanja ; Petkovic, Ana ; Plesinac, Snezana ; Sokic Milutinovic, Aleksandra ; Stojanovic, Maja</creatorcontrib><description>Takayasu arteritis (TA) is a large vessel vasculitis affecting predominantly females below the age of 40. Patients with TA seem to be at increased risk for adverse pregnancy outcomes, resulting in mother or child complications. Although few studies analyzed the presence of antiphospholipid antibodies (APLA) in TA patients, an association between antiphospholipid syndrome (APS) and TA is rarely reported in the literature, mainly in the form of case reports. In fact, very few data regarding pregnancy outcomes in patients with TA and APS are available. An active form of Crohn’s disease (CD) might be another risk factor strongly affecting the fertility rate. Here, we would like to present a 33-year-old woman with TA, double-positive APS and Crohn’s disease (CD). The report is followed by the literature review of the association of APLA and/or APS with TA, focusing on analyzing the pregnancy outcomes. To our knowledge, this is the first case describing two successful, naturally occurring pregnancies, in a patient suffering from TA, APS and CD, and maintained on infliximab, azathioprine, and a corticosteroid-free regimen.</description><identifier>ISSN: 1437-160X</identifier><identifier>ISSN: 0172-8172</identifier><identifier>EISSN: 1437-160X</identifier><identifier>DOI: 10.1007/s00296-023-05440-0</identifier><identifier>PMID: 37653060</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adult ; Antiphospholipid Syndrome - complications ; Antiphospholipid Syndrome - diagnosis ; Antiphospholipid Syndrome - drug therapy ; Autoimmune diseases ; Azathioprine - therapeutic use ; Case Based Review ; Crohn Disease - complications ; Crohn Disease - drug therapy ; Crohn's disease ; Female ; Humans ; Immunosuppressive Agents - therapeutic use ; Infliximab - therapeutic use ; Live Birth ; Medicine ; Medicine & Public Health ; Monoclonal antibodies ; Patients ; Pregnancy ; Pregnancy Outcome ; Rheumatology ; Steroids ; Takayasu Arteritis - complications ; Takayasu Arteritis - drug therapy</subject><ispartof>Rheumatology international, 2024-07, Vol.44 (7), p.1359-1367</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-c990d952132925e2b3ce22364e2816ac38bafc4e27c23981257b6abd1e858a2f3</cites><orcidid>0000-0002-2292-5181 ; 0000-0003-1944-3883 ; 0000-0002-3450-1765 ; 0000-0001-5513-854X ; 0000-0003-4589-7344 ; 0000-0002-8805-8391</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00296-023-05440-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00296-023-05440-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37653060$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jovicic, Zikica</creatorcontrib><creatorcontrib>Dragasevic, Sanja</creatorcontrib><creatorcontrib>Petkovic, Ana</creatorcontrib><creatorcontrib>Plesinac, Snezana</creatorcontrib><creatorcontrib>Sokic Milutinovic, Aleksandra</creatorcontrib><creatorcontrib>Stojanovic, Maja</creatorcontrib><title>Successful pregnancies in a patient with Takayasu arteritis and antiphospholipid syndrome, maintained on infliximab corticosteroid-free regimen: case-based review</title><title>Rheumatology international</title><addtitle>Rheumatol Int</addtitle><addtitle>Rheumatol Int</addtitle><description>Takayasu arteritis (TA) is a large vessel vasculitis affecting predominantly females below the age of 40. Patients with TA seem to be at increased risk for adverse pregnancy outcomes, resulting in mother or child complications. Although few studies analyzed the presence of antiphospholipid antibodies (APLA) in TA patients, an association between antiphospholipid syndrome (APS) and TA is rarely reported in the literature, mainly in the form of case reports. In fact, very few data regarding pregnancy outcomes in patients with TA and APS are available. An active form of Crohn’s disease (CD) might be another risk factor strongly affecting the fertility rate. Here, we would like to present a 33-year-old woman with TA, double-positive APS and Crohn’s disease (CD). The report is followed by the literature review of the association of APLA and/or APS with TA, focusing on analyzing the pregnancy outcomes. To our knowledge, this is the first case describing two successful, naturally occurring pregnancies, in a patient suffering from TA, APS and CD, and maintained on infliximab, azathioprine, and a corticosteroid-free regimen.</description><subject>Adult</subject><subject>Antiphospholipid Syndrome - complications</subject><subject>Antiphospholipid Syndrome - diagnosis</subject><subject>Antiphospholipid Syndrome - drug therapy</subject><subject>Autoimmune diseases</subject><subject>Azathioprine - therapeutic use</subject><subject>Case Based Review</subject><subject>Crohn Disease - complications</subject><subject>Crohn Disease - drug therapy</subject><subject>Crohn's disease</subject><subject>Female</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Infliximab - therapeutic use</subject><subject>Live Birth</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Monoclonal antibodies</subject><subject>Patients</subject><subject>Pregnancy</subject><subject>Pregnancy Outcome</subject><subject>Rheumatology</subject><subject>Steroids</subject><subject>Takayasu Arteritis - complications</subject><subject>Takayasu Arteritis - drug therapy</subject><issn>1437-160X</issn><issn>0172-8172</issn><issn>1437-160X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UUuP1iAUbYzGeegfcGFI3LgY9AItbd1NJr6SSVw4Ju4IpbczjC1ULnX8_o6_VPQbH3Hh4sAFzj0HOFX1SMAzAdA-JwDZaw5ScWjqGjjcqQ5FrVouNHy8-1d9UB0RXQOIVmu4Xx2oVjcKNBxW395vziHRtM1sTXgZbHAeifnALFtt9hgyu_H5il3YT3ZnaWM2ZUw-e2I2jAXZr1eRCma_-pHRLowpLnjCFutDLsCRxVAUp9l_9YsdmIspexep6EQ_8ikhsuLtFwwvmLOEfCjDWPa-eLx5UN2b7Ez48HY-rj68enlx9oafv3v99uz0nDsldeau72HsGymU7GWDclAOpVS6RtkJbZ3qBju5smqdVH0nZNMO2g6jwK7prJzUcfV0r7um-HlDymbx5HCebcC4kZGdhhqE7JtCffIP9TpuKZTbmfKtXXEVbV9Ycs9yKRIlnMyayvvTzggwPxI0-wRNSdD8TNBAaXp8K70NC46_W35FVghqT6ByFC4x_fH-j-x3Mn6p5Q</recordid><startdate>20240701</startdate><enddate>20240701</enddate><creator>Jovicic, Zikica</creator><creator>Dragasevic, Sanja</creator><creator>Petkovic, Ana</creator><creator>Plesinac, Snezana</creator><creator>Sokic Milutinovic, Aleksandra</creator><creator>Stojanovic, Maja</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2292-5181</orcidid><orcidid>https://orcid.org/0000-0003-1944-3883</orcidid><orcidid>https://orcid.org/0000-0002-3450-1765</orcidid><orcidid>https://orcid.org/0000-0001-5513-854X</orcidid><orcidid>https://orcid.org/0000-0003-4589-7344</orcidid><orcidid>https://orcid.org/0000-0002-8805-8391</orcidid></search><sort><creationdate>20240701</creationdate><title>Successful pregnancies in a patient with Takayasu arteritis and antiphospholipid syndrome, maintained on infliximab corticosteroid-free regimen: case-based review</title><author>Jovicic, Zikica ; Dragasevic, Sanja ; Petkovic, Ana ; Plesinac, Snezana ; Sokic Milutinovic, Aleksandra ; Stojanovic, Maja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-c990d952132925e2b3ce22364e2816ac38bafc4e27c23981257b6abd1e858a2f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Antiphospholipid Syndrome - complications</topic><topic>Antiphospholipid Syndrome - diagnosis</topic><topic>Antiphospholipid Syndrome - drug therapy</topic><topic>Autoimmune diseases</topic><topic>Azathioprine - therapeutic use</topic><topic>Case Based Review</topic><topic>Crohn Disease - complications</topic><topic>Crohn Disease - drug therapy</topic><topic>Crohn's disease</topic><topic>Female</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Infliximab - therapeutic use</topic><topic>Live Birth</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Monoclonal antibodies</topic><topic>Patients</topic><topic>Pregnancy</topic><topic>Pregnancy Outcome</topic><topic>Rheumatology</topic><topic>Steroids</topic><topic>Takayasu Arteritis - complications</topic><topic>Takayasu Arteritis - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jovicic, Zikica</creatorcontrib><creatorcontrib>Dragasevic, Sanja</creatorcontrib><creatorcontrib>Petkovic, Ana</creatorcontrib><creatorcontrib>Plesinac, Snezana</creatorcontrib><creatorcontrib>Sokic Milutinovic, Aleksandra</creatorcontrib><creatorcontrib>Stojanovic, Maja</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Rheumatology international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jovicic, Zikica</au><au>Dragasevic, Sanja</au><au>Petkovic, Ana</au><au>Plesinac, Snezana</au><au>Sokic Milutinovic, Aleksandra</au><au>Stojanovic, Maja</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Successful pregnancies in a patient with Takayasu arteritis and antiphospholipid syndrome, maintained on infliximab corticosteroid-free regimen: case-based review</atitle><jtitle>Rheumatology international</jtitle><stitle>Rheumatol Int</stitle><addtitle>Rheumatol Int</addtitle><date>2024-07-01</date><risdate>2024</risdate><volume>44</volume><issue>7</issue><spage>1359</spage><epage>1367</epage><pages>1359-1367</pages><issn>1437-160X</issn><issn>0172-8172</issn><eissn>1437-160X</eissn><abstract>Takayasu arteritis (TA) is a large vessel vasculitis affecting predominantly females below the age of 40. Patients with TA seem to be at increased risk for adverse pregnancy outcomes, resulting in mother or child complications. Although few studies analyzed the presence of antiphospholipid antibodies (APLA) in TA patients, an association between antiphospholipid syndrome (APS) and TA is rarely reported in the literature, mainly in the form of case reports. In fact, very few data regarding pregnancy outcomes in patients with TA and APS are available. An active form of Crohn’s disease (CD) might be another risk factor strongly affecting the fertility rate. Here, we would like to present a 33-year-old woman with TA, double-positive APS and Crohn’s disease (CD). The report is followed by the literature review of the association of APLA and/or APS with TA, focusing on analyzing the pregnancy outcomes. To our knowledge, this is the first case describing two successful, naturally occurring pregnancies, in a patient suffering from TA, APS and CD, and maintained on infliximab, azathioprine, and a corticosteroid-free regimen.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>37653060</pmid><doi>10.1007/s00296-023-05440-0</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-2292-5181</orcidid><orcidid>https://orcid.org/0000-0003-1944-3883</orcidid><orcidid>https://orcid.org/0000-0002-3450-1765</orcidid><orcidid>https://orcid.org/0000-0001-5513-854X</orcidid><orcidid>https://orcid.org/0000-0003-4589-7344</orcidid><orcidid>https://orcid.org/0000-0002-8805-8391</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1437-160X |
ispartof | Rheumatology international, 2024-07, Vol.44 (7), p.1359-1367 |
issn | 1437-160X 0172-8172 1437-160X |
language | eng |
recordid | cdi_proquest_miscellaneous_2860401295 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Adult Antiphospholipid Syndrome - complications Antiphospholipid Syndrome - diagnosis Antiphospholipid Syndrome - drug therapy Autoimmune diseases Azathioprine - therapeutic use Case Based Review Crohn Disease - complications Crohn Disease - drug therapy Crohn's disease Female Humans Immunosuppressive Agents - therapeutic use Infliximab - therapeutic use Live Birth Medicine Medicine & Public Health Monoclonal antibodies Patients Pregnancy Pregnancy Outcome Rheumatology Steroids Takayasu Arteritis - complications Takayasu Arteritis - drug therapy |
title | Successful pregnancies in a patient with Takayasu arteritis and antiphospholipid syndrome, maintained on infliximab corticosteroid-free regimen: case-based review |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T13%3A09%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Successful%20pregnancies%20in%20a%20patient%20with%20Takayasu%20arteritis%20and%20antiphospholipid%20syndrome,%20maintained%20on%20infliximab%20corticosteroid-free%20regimen:%20case-based%20review&rft.jtitle=Rheumatology%20international&rft.au=Jovicic,%20Zikica&rft.date=2024-07-01&rft.volume=44&rft.issue=7&rft.spage=1359&rft.epage=1367&rft.pages=1359-1367&rft.issn=1437-160X&rft.eissn=1437-160X&rft_id=info:doi/10.1007/s00296-023-05440-0&rft_dat=%3Cproquest_cross%3E2860401295%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3068236179&rft_id=info:pmid/37653060&rfr_iscdi=true |